Adjuvant Chemotherapy

In this video, Afsaneh Barzi, MD, PhD, discussed the phase 2 results from the NRG-GI005 (COBRA) study.

Deteriorating quality of life for women with breast cancer was associated with many common modifiable psychosocial and lifestyle-related factors, according to an analysis published in JAMA Network Open.

Gemcitabine and platinum chemotherapy administered after nephroureterectomy SIGNIFICSALTY improved OS among certain patients with upper tract urothelial carcinoma, updated results form a randomized phase 3 study showed.

Circulating tumor DNA did not successfully predict whether patients with resected stage II colon cancer would benefit from adjuvant chemotherapy, according to findings presented at ASCO Gastrointestinal Cancers Symposium.

Circulating tumor DNA-based detection of molecular residual disease appeared to be highly prognostic of patient outcomes, according to data presented at ASCO Gastrointestinal Cancers Symposium.

Black individuals with early-onset colorectal cancer received worse and less timely care compared with white patients, according to results of a national hospital-based study.

The addition of pembrolizumab to perioperative chemotherapy failed to significantly extend EFS among patients with locally advanced resectable gastric and gastroesophageal junction adenocarcinoma, according to the agent’s manufacturer.

Adjuvant chemotherapy appeared associated with a significant survival benefit among patients with pancreatic ductal adenocarcinoma who underwent multiagent neoadjuvant chemotherapy and resection, according to study results.

CHICAGO — The addition of chemotherapy to endocrine therapy did not extend OS after surgery among older patients with ER-positive, HER2-negative breast cancer with a high tumor genomic grade index.

Premenopausal women with node-positive breast cancer and low recurrence scores benefited from adjuvant chemotherapy, whereas postmenopausal women did not, according to results of a study published in The New England Journal of Medicine.